Post by Longwood Healthcare Leaders

Some of the sharpest minds in #biopharma R&D will come together at #MITCEO this June 15-16 at the MIT Koch Institute for Integrative Cancer Research. From fireside chats to deep-dive panels, leaders in the industry will dive deep into candid conversation on topics from pipeline sourcing to late-stage assets, #RNAi breakthroughs to drug approvals as Longwood Healthcare Leaders hosts a series of candid, #offtherecord discussions across the full arc of drug development. Featured R&D voices include: Uli Broedl, Grünenthal Group Kevin Fitzgerald, Alnylam Pharmaceuticals Pushkal Garg, Alnylam Levi Garraway, Roche Genentech William N. Hait, Johnson & Johnson (former); AACR Fiona H. Marshall, Novartis Sarah Sheikh, Takeda Morten Sogaard, Astellas Pharma george yancopoulos, Regeneron See the agenda and reserve your seat now: https://lnkd.in/gNgNseFU #Pharma #Biotech #DrugDiscovery #LifeSciences #MITCEO #ResearchandDevelopment Longwood Fund Christoph Westphal